Skip to main content
Springer logoLink to Springer
. 2022 Oct 14;115(11):1363–1378. doi: 10.1007/s10482-022-01779-9

Identification of fungal dihydrouracil-oxidase genes by expression in Saccharomyces cerevisiae

Jonna Bouwknegt 1,#, Aurin M Vos 1,#, Raúl A Ortiz Merino 1, Daphne C van Cuylenburg 1, Marijke A H Luttik 1, Jack T Pronk 1,
PMCID: PMC9585004  PMID: 36241945

Abstract

Analysis of predicted fungal proteomes revealed a large family of sequences that showed similarity to the Saccharomyces cerevisiae Class-I dihydroorotate dehydrogenase Ura1, which supports synthesis of pyrimidines under aerobic and anaerobic conditions. However, expression of codon-optimised representatives of this gene family, from the ascomycete Alternaria alternata and the basidiomycete Schizophyllum commune, only supported growth of an S. cerevisiae ura1Δ mutant when synthetic media were supplemented with dihydrouracil. A hypothesis that these genes encode NAD(P)+-dependent dihydrouracil dehydrogenases (EC 1.3.1.1 or 1.3.1.2) was rejected based on absence of complementation in anaerobic cultures. Uracil- and thymine-dependent oxygen consumption and hydrogen-peroxide production by cell extracts of S. cerevisiae strains expressing the A. alternata and S. commune genes showed that, instead, they encode active dihydrouracil oxidases (DHO, EC1.3.3.7). DHO catalyses the reaction dihydrouracil + O2 → uracil + H2O2 and was only reported in the yeast Rhodotorula glutinis (Owaki in J Ferment Technol 64:205–210, 1986). No structural gene for DHO was previously identified. DHO-expressing strains were highly sensitive to 5-fluorodihydrouracil (5F-dhu) and plasmids bearing expression cassettes for DHO were readily lost during growth on 5F-dhu-containing media. These results show the potential applicability of fungal DHO genes as counter-selectable marker genes for genetic modification of S. cerevisiae and other organisms that lack a native DHO. Further research should explore the physiological significance of this enigmatic and apparently widespread fungal enzyme.

Supplementary Information

The online version contains supplementary material available at 10.1007/s10482-022-01779-9.

Keywords: Dihydroorotate dehydrogenase, Dihydropyrimidine dehydrogenase, Dihydropyrimidine oxidase, Counter-selectable marker genes, 5-fluorodihydrouracil, Dihydrothymine

Introduction

Cellular contents of the pyrimidines cytidine, thymine and uracil are the net result of uptake, de novo synthesis, salvage pathways and degradation (di Carlo et al. 1952; O’Donovan and Neuhard 1970). Whereas pyrimidine biosynthesis is highly conserved across all domains of life (O’Donovan and Neuhard 1970), pyrimidine degradation can occur via at least four different pathways (Hayaishi and Kornberg 1952; Vogels and van der Drift 1976; Loh et al. 2006; Andersen et al. 2008). The conserved pyrimidine biosynthesis pathway and the reductive pathway for pyrimidine degradation that occurs in most eukaryotes (Vogels and van der Drift 1976; Zrenner et al. 2006) involve similar, reversible redox reactions (Moffatt and Ashihara 2002). In pyrimidine biosynthesis, dihydroorotate dehydrogenase (DHOD) oxidises dihydroorotate to orotate (Fig. 1A), while the reductive pyrimidine degradation pathway starts with reduction of uracil to dihydrouracil (Fig. 1B) by NAD(P)+-dependent dihydropyrimidine dehydrogenases (DHPD), whose protein sequences show similarity to those of DHODs (Rowland et al. 1997; Dobritzsch et al. 2001). The DHPDs active in pyrimidine degradation, as well as the DHODs active in pyrimidine synthesis, are flavoproteins.

Fig. 1.

Fig. 1

Reactions catalysed by dihydroorotate dehydrogenase, dihydropyrimidine dehydrogenase and dihydrouracil oxidase. a. In pyrimidine biosynthesis, fungal dihydroorotate dehydrogenase catalyses the oxidation of dihydroorotate orotate and donates electrons to the quinone pool of the respiratory chain (Class-II DHOD, but see (Bouwknegt et al. 2021)) or to fumarate (Class-I DHOD). b. In the reductive pathway for pyrimidine degradation, dihydropyrimidine dehydrogenases (DPHD) catalyse the reduction of uracil to dihydrouracil, using NAD(P)H + H+ as electron donor. c. Dihydrouracil oxidase (DHO), which has only been described in Rhodotorula glutinis (Davis et al. 1984; Owaki et al. 1986), catalyses oxidation of dihydrouracil with molecular oxygen and forms hydrogen peroxide

Genetic defects in human pyrimidine catabolism have been implicated in neurological disorders and mainly affect DHPD (Berger et al. 1984; van Kuilenburg et al. 1999). Furthermore, human DHPD plays a key role in resistance to the anticancer drug 5-fluorouracil (5-FU) by reducing it to the less toxic 5-fluorodihydroxyuracil (Heggie et al. 1987; Hull et al. 1988; Van Gennip et al. 1997; van Kuilenburg et al. 1999). Eukaryotic DHPDs, encoded by mammalian DPYD orthologs and plant PYD1 orthologs, have been isolated and characterised (Smith and Yamada 1971; Podschun et al. 1989; Zrenner et al. 2009). They are homodimers containing one FAD, one FMN and four [4Fe-4S] clusters (Podschun et al. 1989; Lu et al. 1992). After reduction of the FAD cofactor with NADPH, electrons are transferred to FMN via the [4Fe-4S] clusters and FMNH2 reduces uracil or thymine, yielding dihydrouracil or dihydrothymine, respectively (Podschun et al. 1990).

Most fungi harbour homodimeric Class-II DHODs, which are targeted to the outside of the inner mitochondrial membrane (Rawls et al. 2000). These enzymes, which are orthologs of the Ura9 proteins in yeasts such as Lachancea kluyveri and Ogataea parapolymorpha, donate electrons to the quinone pool of the mitochondrial respiratory chain (Gojković et al. 2004; Fonseca et al. 2008; Riley et al. 2016). As a consequence, the large majority of fungi require oxygen for pyrimidine synthesis (Nagy et al. 1992). The facultative anaerobic Saccharomyces species and a small number of closely related Saccharomycotina yeasts, including facultatively anaerobic as well as oxygen-requiring species, instead harbour Class I-A DHODs (Ura1 in S. cerevisiae). These enzymes are soluble homodimers with one FMN domain per subunit and use fumarate as electron acceptor (Zameitat et al. 2007).

Presence of Ura1 orthologs, which in Saccharomycotina are proposed to have been acquired by horizontal gene transfer (HGT) from lactic acid bacteria (Gojković et al. 2004), were long considered to be essential for anaerobic pyrimidine prototrophy of fungi (Hall et al. 2005). This notion was first questioned when the facultatively anaerobic yeast Dekkera bruxellensis was shown to only contain a DHOD gene with sequence similarity to yeast Class-II DHOD genes (Woolfit et al. 2007; Piškur et al. 2012). We recently showed that expression of Class-II DHOD genes from D. bruxellensis, from obligately anaerobic Neocallimastigomycota, or from the facultatively anaerobic fission yeast Schizosaccharomyces japonicus, supported anaerobic growth of S. cerevisiae ura1Δ strains without pyrimidine supplementation (Bouwknegt et al. 2021). These results indicated that acquisition of a Class-I DHOD by HGT is not the only mechanism by which fungi can evolve for anaerobic pyrimidine prototrophy.

While searching fungal proteomes for homologs of S. cerevisiae Ura1 that might indicate previously unidentified HGT events leading to the acquisition of Class-I DHODs, we encountered an unexpectedly large number of putative proteins in ascomycetes and basidiomycetes that showed similarity to Class-I DHOD sequences. A widespread occurrence of Ura1 orthologs in fungi was unexpected in view of the previously reported connection of Class-I DHOD genes to anaerobic growth and the proposed role of HGT in their acquisition. To investigate the biochemical function of the proteins encoded by this previously unexplored fungal gene family, we expressed representatives from the ascomycete Alternaria alternata and the basidiomycete Schizophyllum commune in a ura1Δ strain of Saccharomyces cerevisiae. Since S. cerevisiae and other post-whole-genome-duplication Saccharomycotina yeast species lost the ability to degrade pyrimidines (Andersen et al. 2006), expression in ura1Δ strains enabled analysis of DHOD and DHPD activity of the encoded proteins as well as an assessment on the requirement for oxygen of their activities. Growth experiments and enzyme activity assays in cell extracts showed that the A. alternata and Sch. commune genes encoded dihydrouracil oxidases (DHO) that catalyse oxygen-dependent oxidation of dihydrouracil to uracil (Fig. 1C) and also showed activity with dihydrothymine. Based on the reported ability of human DHPD to convert 5-fluorodihydrouracil to the toxic compound 5-fluorouracil (Heggie et al. 1987), we tested whether fungal dho genes can be applied as counter-selectable marker genes for genetic modification of S. cerevisiae.

Results

Genome analysis reveals a large cluster of uncharacterised fungal protein sequences with similarity to yeast Ura1

To search fungal proteomes for possible Class-I-A DHODs resembling the Ura1 proteins of S. cerevisiae and closely related Saccharomycotina yeasts, the amino-acid sequence of the Class-I-A DHOD LkUra1 from Lachanchea kluyveri was used as query for a HMMER search against fungal proteomes available from Uniprot (The Uniprot Consortium 2019). This search yielded 203 putative Ura1 orthologs (Fig. 2, Dataset S01, S02). Eight of these proteins originating from Mucoromycotina showed a strong homology to the well-known Class-I-A DHODs from S. cerevisiae, L. kluyveri and other Saccharomycotina yeasts (Fig. 2), despite the phylogenetic distance of these groups (Li et al. 2021). This observation coincided with the reported ability of dimorphic Mucor species to grow anaerobically without pyrimidine supplementation (Bartnicki-Garcia and Nickerson 1962; Jeennor et al. 2006). A large group of additional putative orthologs of LkUra1 in Ascomycota and Basidiomycota (Fig. 2) was unexpected, since the only known fungal Class-I-A DHODs are proposed to have been obtained by horizontal gene transfer (Gojković et al. 2004). Most of these sequences were found in proteomes of aerobic fungi that also contain a Class-II DHOD (Bouwknegt et al. 2021). This observation raised the question whether and why these organisms harbour different, seemingly redundant DHODs. The group of putative Ura1-orthologs showed two large clusters, which almost exclusively consisted of sequences from either ascomycetes or basidiomycetes. Only two sequences from basidiomycetes (Exidia glandulosa; A0A166AFZ8 and Cutaneotrichonsporon oleaginosum; A0A0J0XZ95) clustered with those from ascomycetes (Fig. 2). We therefore hypothesised that, rather than DHODs, this group of LkUra1-like protein sequences in ascomycetes and basidiomycetes might comprise proteins with a related function, such as DHPDs (Dobritzsch et al. 2001).

Fig. 2.

Fig. 2

Maximum likelihood phylogenetic tree of L. kluyveri (LkUra1; dihydroorotate dehydrogenase) fungal orthologs. A search for orthologs of Class I-A dihydroorotate dehydrogenases using Lachancea kluyveri LkUra1 (UniProt KB accession number: Q7Z892) as query resulted in 203 proteins (Dataset S01). Sequence identifiers corresponding to the phyla Basidiomycota, Ascomycota and Mucoromycota are indicated in color. Sequences that were functionally analysed in this study, as well as the the characterised Ura1 proteins of L. kluyveri (Gojković et al. 2004), and S. cerevisiae (Zameitat et al. 2007) are indicated with the corresponding species name. The tree was midpoint rooted, and the raw phylogenetic tree is provided in Dataset S02. Bootstrap values and species can be accessed from: https://itol.embl.de/tree/8384480104951618225493

Putative Ura1-orthologs from A. alternata and Sch. commune are not DHODs

To investigate the biochemical activity of the group of fungal proteins with sequence similarity to S. cerevisiae Ura1, a representative from an ascomycete (Alternaria alternata; Aa; A0A177DSV5) and a basidiomycete (Schizophyllum commune; Sc; D8QKJ0) were selected (Fig. 2). An alignment of these sequences with those of Ura1 orthologs from L. kluyveri and S. cerevisiae confirmed the strong similarity inferred from the phylogenetic analyses (SI Figure S1). Conserved amino-acid residues involved in flavin cofactor binding, as well as an active-site cysteine residue that is strongly conserved in Class-I-A DHODs occurred in all four sequences. Codon-optimised coding regions of the corresponding genes, further referred to as Aadho and Scdho (see below), respectively, were expressed in the uracil-auxotrophic S. cerevisiae strain IMK824 (ura1∆), which lacks DHOD activity and whose growth on synthetic medium with glucose (SMD) should therefore require supplementation with uracil (SMD + ura; Fig. 1; Hall et al. 2005). Since the S. cerevisiae genome does not encode a DHPD (Andersen et al. 2006), in vivo DHOD activity of the heterologous proteins should complement the ura1∆ mutation on SMD, while in vivo DHPD activity should only do so upon supplementation of media with dihydrouracil (SMD + dhu; Fig. 1). As anticipated, the reference S. cerevisiae strain IMX585 (URA1) showed the same specific growth rate (0.37 h−1) on all three media, while strain IMK824 (ura1∆) only grew on SMD + ura supplemented with uracil (Table 1). The latter, IMK824, grew slightly slower on SMD + ura than the reference strain (Table 1), probably reflecting a limitation in uracil import (Pronk 2002). Strains IMI433 (ura1::Aadho) and IMI434 (ura1∆::Scdho) did not show growth on SMD (Table 1), indicating that the heterologous fungal genes were either not functionally expressed in S. cerevisiae or did not encode functional DHODs. The subsequent observation that both strains showed a specific growth rate of 0.34 h−1 on SMD + dhu, which did not support growth of the ura1∆ strain IMK824 (Table 1), led us to hypothesise that Aadho and Scdho both encode fungal DHPDs.

Table 1.

Complementation by uracil (ura) or dihydrouracil (dhu) of uracil-auxotrophic S. cerevisiae strains expressing fungal proteins with homology to Ura1

Strain Relevant genotype SMD SMD + ura SMD + dhu
IMX585 URA1 0.37 ± 0.00 0.37 ± 0.00 0.37 ± 0.01
IMK824 ura1Δ n.a 0.35 ± 0.00 n.a
IMI433 ura1Δ::Aadho n.a 0.37 ± 0.00 0.34 ± 0.00
IMI434 ura1Δ::Scdho n.a 0.35 ± 0.00 0.34 ± 0.01

Specific growth rates were measured in duplicate shake-flask cultures for each combination of strain and medium composition, data are represented as average ± mean deviation. SMD, synthetic medium with glucose; SMD + ura, SMD supplemented with 1.5 g L−1 uracil; SMD + dhu, SMD supplemented with 2.5 g L−1 dihydrouracil. n.a. (not applicable) indicates that no exponential growth was observed

S. cerevisiae strains expressing Aadho or Scdho do not oxidise dihydrouracil in anaerobic cultures

To test whether dihydrouracil oxidation by strains IMI433 (ura1::Aadho) and IMI434 (ura1∆::Scdho) required oxygen, their anaerobic growth was compared with that of the reference strains IMX585 and IMK824 (ura1Δ). After aerobic pre-cultivation on permissive synthetic media, washed cell suspensions were transferred to second-stage anaerobic pre-cultures on SMUD with a limiting amount of uracil (SMUD + ura0.1) or dihydrouracil (SMUD + dhu0.1). Upon a subsequent transfer, strain IMK824 (ura1∆) did not grow on SMUD unless uracil was supplemented (Fig. 3). This result confirmed that the pre-cultivation procedure had successfully depleted any intracellular reserves of pyrimidines. When the S. cerevisiae strains expressing either Aadho or Scdho were similarly transferred to an anaerobic culture, no growth on SMUD or SMUD + dhu was observed (Fig. 3). However, when anaerobic cultures of these strains on SMD + dhu were subsequently transferred to aerobic conditions, instantaneous growth occurred (Fig. 3). These results showed that oxygen is required for in vivo oxidation of dihydrouracil by Aadho and Scdho-encoded proteins.

Fig. 3.

Fig. 3

Anaerobic growth curves of S. cerevisiae strains expressing genes encoding putative Ura1 orthologs from Alternaria alternata (Aadho) and Schizophyllum commune (Scdho). Strains were pre-grown anaerobically (Black circle) on medium with a limiting amount of uracil (strain IMK824 (ura1Δ)) or dihydrouracil (strains IMX585 (URA1), IMI433 (ura1Δ::Aadho) and IMI434 (ura1Δ::Scdho) to deplete intracellular pyrimidine reserves (grey boxes; Mooiman et al. 2021). Strains were then transferred to fresh media with dihydrouracil (SMD + dhu; Black Square) or without dihydrouracil (SMD; White circle). After 62 h (dotted line), strains IMI433 and IMI434 were transferred to aerobic conditions. a; S. cerevisiae IMX585 (URA1), b; strain IMK824 (ura1Δ), c; strain IMI433 (ura1Δ::Aadho), d; strain IMI434 (ura1Δ::Scdho). Data represent the average and mean deviation of duplicate cultures

Aadho and Scdho encode dihydrouracil oxidases

The observed oxygen requirement for dihydrouracil oxidation of S. cerevisiae strains expressing Aadho or Scdho raised the possibility that these genes might encode dihydrouracil oxidases (DHO; Fig. 1, Davis et al. 1984). To test this hypothesis, expression cassettes were introduced in an S. cerevisiae ura1∆ background on multicopy (mc) plasmids. Cell extracts of the resulting strains IME664 (ura1∆ mcAadho) and IME665 (ura1∆ mcScdho) were then used for enzyme activity assays. Extracts of strains IME664 and IME665 showed dihydrouracil-dependent oxygen consumption (Table 2; 29.6 ± 6.5 and 246 ± 13 nmol O2 (mg protein)−1 min−1, respectively) as well as dihydrothymine-dependent oxygen consumption (46.1 ± 8.6 and 340 ± 22 nmol O2 (mg protein)−1 min−1). No significant rates of oxygen consumption were observed upon addition of dihydrouracil or dihydrothymine to cell extracts of the reference strains CEN.PK113-7D (URA1) or IMK824 (ura1∆) (Table 2). When catalase, which catalyses the reaction 2 H2O2 → O2 + 2 H2O, was added during oxidation of dihydrouracil by cell extracts of strains IME664 or IME665, the oxygen concentration in the reaction mixture immediately increased (Fig. 4). This increase corresponded to about 40% of the initially consumed oxygen rather than the theoretically predicted 50%. This observation is likely to be due to the presence of some catalase in the yeast cell extracts. These results supported the hypothesis that Aadho and Scdho are structural genes encoding active fungal DHO enzymes.

Table 2.

Substrate-dependent oxygen-uptake activities of cell extracts of S. cerevisiae strains expressing Aadho or Scdho

Strain Relevant genotype Activity (nmol O2·mg protein−1·min−1)
dihydrouracil dihydrothymine
CEN.PK113-7D URA1  < 2  < 2
IMK824 ura1  < 2  < 2
IME664 ura1∆ mcAadho 29.6 ± 6.5 46.1 ± 8.6
IME665 ura1∆ mcScdho 246 ± 13 340 ± 22

Activities were determined in cell extracts by monitoring oxygen upon addition of 1 mM dihydrouracil or 1 mM dihydrothymine. Experiments were performed with a Clark-type oxygen electrode, in a 4 mL reaction chamber kept at 30 °C and containing 0.1 M potassium phosphate buffer (pH 7.5) with 2 mM MgCl2. Activities are presented as average and mean deviation of measurements on two independently prepared cell extracts for each strain

Fig. 4.

Fig. 4

Substrate-dependent oxygen consumption and catalase-dependent oxygen formation by cell extracts of S. cerevisiae strains expressing fungal dihydrouracil oxidases. Reaction volumes of 4 mL contained cell extracts of a. S. cerevisiae IME664 (Aadho), b. S. cerevisiae IME665 (Scdho). Oxygen concentration was monitored with a Clark-type electrode. Arrows indicate the following additions: 1; 1 mM dihydrothymine (black lines) or 1 mM dihydrouracil (red lines), 2; approximately 500 U catalase

DHO activity was previously only reported in two studies on Rhodotorula glutinis (Davis et al. 1984; Owaki et al. 1986). Since the proteome of R. glutinis is not available from Uniprot, no Ura1-ortholog of this yeast was included in our phylogenetic analysis. However, homologous proteins were found in Rhodotorula species, R. taiwanensis (A0A2S5B0X9) and R. graminis (A0A194S2Z2) as well as in a predicted protein sequence derived from the R. glutinis genome sequence available at JGI Mycocosm (Grigoriev et al. 2014). Although, similar to our results (Table 2), the early studies on R. glutinis indicated activity with dihydrouracil as well as dihydrothymine, the enzyme activity was classified as a dihydrouracil oxidase (EC1.3.3.7). We therefore propose the name dho (for dihydrouracil oxidase) for the genes encoding A0A177DSV5 from Alternaria alternata (Aadho) and D8QKJ0 from Schizophyllum commune (Scdho).

Aadho and Scdho can be used as dominant counter-selectable marker genes in uracil-auxotrophic S. cerevisiae mutants

Based on the observation that expression of the two fungal dho genes enabled uracil-auxotrophic mutants of S. cerevisiae to grow on SMD + dhu, we explored whether they might be applicable as counter-selectable dominant marker genes in such strains. To this end, we investigated whether the DHOs encoded by Aadho and Scdho convert 5-fluorodihydrouracil (5F-dhu) into the toxic compound 5-fluorouracil (5-FU), as has been described for mammalian DHPDs (Shiotani and Weber 1981; Heggie et al. 1987). The two DHO-expressing strains S. cerevisiae IMI433 and IMI434, the uracil-auxotrophic strains IMX581 (ura3∆) and IMK824 (ura1∆) and the reference strain IMX585 (URA1) were plated on SMD + ura and on SMD with 5F-dhu and uracil. Growth of the reference strain IMX585 was not substantially affected by 5F-dhu (Fig. 5). In contrast, 5F-dhu strongly inhibited growth of the DHO-expressing strains and even completely blocked growth of strain IMI433 (ura1∆::Aadho). Growth of the ura1 and ura3 null mutants IMK824 and IMX581 on SMD + ura was also inhibited by 5F-dhu, to similar extent as the inhibition observed for strain IMI434 (ura1∆::Scdho). This observation suggests that 5F-dhu inhibits uracil uptake via the S. cerevisiae Fur4 transporter (Jund et al. 1988). The much stronger growth inhibition by 5F-dhu observed for strain IMI433 indicates that AaDho has activity towards this substrate while, based on the growth assays on plates, no conclusion could be drawn on whether the same holds for ScDho.

Fig. 5.

Fig. 5

Effect of 5-fluorodihydrouracil on growth of S. cerevisiae strains expressing fungal dihydrouracil oxidases. Strains IMX585 (URA1), IMK824 (ura1 null mutant) and IMX581 (ura3 null mutant), IMI433 (ura1Δ::Aadho) and IMI434 (ura1Δ::Scdho) were plated on synthetic medium with 20 g L−1 glucose (SMD; left), medium supplied with 150 mg L−1 uracil (SMD + ura; middle) and SMD supplied with 50 mg L−1 dihydrouracil and 2.5 g L−1 of 5-fluorodihydrouracil (SMD + ura0.3 + 5F-dhu; right) and incubated aerobically at 30 °C for 2 days. Duplicate experiments yielded the same results

To explore counter selection, Aadho and Scdho were expressed in a ura3 null mutant of S. cerevisiae from a plasmid that also carried a URA3 marker gene. These strains were then tested for plasmid loss and viability after growth on SMD + ura with and without 5F-dhu. The reference strain IME426, which contained the URA3-carrying empty plasmid, showed the same viability after growth on SMD + ura with and without 5F-dhu (Table 3). The fraction of viable cells of this strain that had lost the plasmid after growth on SMD + ura with 5F-dhu was lower than after growth on SMD + ura (50% vs. 67%; Table 3). This observation was consistent with the hypothesis that 5F-dhu inhibits uracil uptake.

Table 3.

Effect of 5-fluorodihydrouracil on viability and plasmid loss of S. cerevisiae strains expressing the fungal dihydrouracil oxidase genes Aadho and Scdho

Strain Relevant genotype CFU (%) Plasmid loss (%)
SMD + ura SMD + ura0.1 + 5F-dhu SMD + ura SMD + ura0.1 + 5F-dhu
IME426 ura3-52 pUD63 (URA3) 84 ± 2 87 ± 1 67 ± 2 50 ± 1
IME410 ura3-52 pUDE736 (URA3 Aadho) 92 ± 2 44 ± 6 61 ± 3 99 ± 0
IME414 ura3-52 pUDE737 (URA3 Scdho) 91 ± 0 57 ± 5 60 ± 2 94 ± 1

Yeast strains were grown until late-exponential phase on either SMD with 1.5 g L−1 uracil (SMD + ura) or on SMD supplemented with both 0.15 g L−1 uracil (SMD + ura0.1) and 2.5 g L−1 5F-dhu. Viability was calculated as the percentage of 768 cells plated on SMD + ura that formed colonies. Plasmid loss was calculated from the ratio of cell counts after plating on SMD and SMD + ura. Results are presented as the average ± mean deviation of data obtained with duplicate cultures for each strain

In contrast to the empty-plasmid control strain, S. cerevisiae strains harbouring plasmid-borne expression cassettes for Aadho (IME410) or Scdho (IME414) showed a 2.1-fold and 1.6-fold lower fraction of viable cells, respectively, after growth on SMD + ura with 5F-dhu than after growth on SMD + ura. This indication that 5F-dhu was toxic for both strains was even more strongly supported by the observation that, after growth on SMD + ura with 5F-dhu, strains IME414 (expressing Aadho), IME410 (expressing Scdho) showed plasmid losses of 99.4% and 93%, respectively. This difference was consistent with results from growth experiments with strains expressing a single copy of the dho genes, in which strain IMI433 showed a stronger growth inhibition by 5F-dhu than strain IME434 (Fig. 5). In contrast, DHO activities were higher in cell extracts of S. cerevisiae IME665, which expressed ScDho, than in the AaDho-expressing strain IME664 (Table 2). These results indicate that Aadho can be effectively selected against by growth of S. cerevisiae strains in non-selective medium supplemented with 5F-dhu.

Discussion

The anaerobic pyrimidine prototrophy of Saccharomyces cerevisiae has been attributed to the acquisition by horizontal gene transfer (HGT) of a Class I-DHOD-encoding gene from a lactic acid bacterium (Gojković et al. 2004). This study was originally initiated to explore whether similar HGT events involving Class I-DHOD-encoding gene occurred in fungi outside the Saccharomycotina subdivision. Consistent with a brief literature mention that Mucor DHOD resembles Class I-A DHODs (Oliver et al. 2016), we identified orthologs of Saccharomycotina Ura1 DHOD proteins in proteomes of Mucoromycetes. Strong sequence similarity of these proteins to Class-I DHODs from gram-negative Neisseriacaea (Table S1) supported occurrence of a second, independent bacterium-to-fungus transfer of a Class-I DHOD gene. Involvement in the reported pyrimidine-prototrophic anaerobic growth of Mucor species (Bartnicki-Garcia and Nickerson 1962) can be investigated by complementation studies with an S. cerevisiae ura1∆ strain.

Our search for potential HGT events involving Class-I DHODs unexpectedly identified a large cluster of ascomycete and basidiomycete sequences that all showed sequence homology with Class-I DHOD proteins. Expression of two genes encoding representatives from this cluster, one from an ascomycete and one from a basidiomycete, in an S. cerevisiae ura1Δ strain failed to complement its uracil prototrophy. However, the resulting strains did show oxygen-dependent growth when dihydrouracil was added to growth media (Table 1, Fig. 3). Despite their sequence similarity with Class-I DHOD from the yeasts L. kluyveri and S. cerevisiae (SI Figure S1), these fungal genes were found to encode dihydrouracil oxidases (DHO, EC1.3.3.7). Before this study, DHO activity had only been reported in two publications on the yeast Rhodotorula glutinis (Davis et al. 1984; Owaki et al. 1986) and no structural gene for DHO had been identified.

Our results show that fungal dho genes can be used as counter-selectable marker genes in uracil-auxotrophic S. cerevisiae strains. While use of 5-fluoroorotic acid already allows for efficient counterselection of the frequently used URA3 marker gene in this yeast (Längle-rouault and Jacobs 1995), use of dho as marker gene should enable two consecutive selective transformations based on the ura3 mutation. In a first transformation, dho gene can be used by selecting for dihydrouracil-dependent growth, after which URA3 can still be used by selecting for growth in the absence of dihydrouracil. Simultaneous counterselection against dho and URA3 could then potentially be performed in medium containing 5-fluorodihydrouracil and 5-fluoroorotic acid.

A phylogenetic analysis (Fig. 2) indicated that dho genes probably occur in a wide range of ascomycetes and basidiomycetes, which raises intriguing questions about the physiological role of DHO in fungi. Dihydrouracil and dihydrothymine, the substrates of DHO, are intermediates of the reductive pathway for pyrimidine degradation, which also provides β-alanine for pantothenate synthesis (Cambell 1956; Vogels and van der Drift 1976). In addition, ultraviolet radiation induces conversion of pyrimidines in DNA into dihydrouracil, dihydrothymine and dihydrocytosine (Wierzchowski and Schugar 1957; Yakovlev et al. 1995). Subsequent base- or nucleotide excision repair can lead to direct or indirect release of these dihydropyrimidines in cells (Venkhataraman et al. 2001). Studies on cancer cells and on in vitro DNA replication in Xenopus egg extracts showed that dihydropyrimidines cause DNA–protein crosslinking, interfere with DNA replication and cause transcriptional stress (Basbous et al. 2020). In mammalian cells, the zinc metalloprotein dihydropyrimidinase plays a key role in dihydropyrimidine detoxification (Brooks et al. 1979; Kikugawa et al. 1994). Dihydropyrimidinase in the yeast L. kluyveri was also shown to be a zinc metalloprotein (Dobritzsch et al. 2005) and, based on sequence similarity, this enzyme probably occurs in many other fungi (Dataset_S03). DHO might contribute to dihydropyrimidine detoxification when zinc limitation or other factors prevents optimal activity of dihydropyrimidinase.

Sequence similarity of fungal DHOs and Class-I-A DHODs includes shared conserved residues for flavin binding and in their putative catalytic sites (Figure S1), while no indications were found for binding of the four [4Fe-4S] clusters that occur in homodimeric mammalian DHDPs. In view of this sequence similarity, the reactions catalysed by Class-I-A DHOD and DHO (a flavin-mediated reduction of fumarate and an oxidase reaction, respectively) appear remarkably different. However, Class-I DHODs as well as quinone-dependent Class-II DHODs show low rates of oxygen-dependent dihydroorotate oxidation (Björnberg et al. 1997; Zameitat et al. 2007; Arakaki et al. 2008; Hey-Mogensen et al. 2014). Structure–function analysis should resolve the structural factors that determine their different electron donor and electron acceptor specificities of Class-I DHODs and DHOs and contribute to dissection of the evolutionary histories of these intriguing enzymes.

Methods

Growth media

Sterile synthetic medium with vitamins supplemented with 20 g L−1 D-glucose (SMD) for growth of S. cerevisiae was prepared as described previously (Verduyn et al. 1992). Anaerobic cultures were grown on synthetic medium with vitamins and urea as nitrogen source (SMUD), supplemented with the anaerobic growth factors Tween 80 and ergosterol (Luttik et al. 2000). Uracil was added to media as an autoclaved (121 °C, 20 min) 3.75 g L−1 solution, to final concentrations of either 0.15 g L−1 (SM(U)D + ura), 50 mg L−1 (SM(U)D + ura0.3) or 15 mg L−1 (SM(U)D + ura0.1). When indicated, dihydrouracil (Sigma-Aldrich, St. Louis MO) was added to media prior to sterilisation, to a concentration of 0.15 g L−1. Similarly, a filter-sterilised stock solution of 5-fluorodihydrouracil (5F-dhu; abcr GmbH, Karlsruhe, Germany) was added to sterile medium to a concentration of 2.5 g L−1 where indicated. Yeast extract-peptone-dextrose medium (YPD) was prepared as described previously (Mans et al. 2017). For selection of strains harbouring the kanMX gene, 200 mg L−1 geneticin (G418) was added to YPD. Escherichia coli cultures were grown on Lysogeny Broth (LB; Bertani 1951), autoclaved at 121 °C for 20 min and supplemented with 100 mg L−1 ampicillin (LB-amp). Solid media were prepared by adding 20 g L−1 Bacto Agar (BD Biosciences).

Strains and maintenance

S. cerevisiae strains used in this study (Table 4) were derived from the CEN.PK lineage (Entian and Kötter 2007). For preparation of frozen stock cultures, yeast strains were pre-grown on SMD + ura (Verduyn et al. 1992). Plasmid-containing E. coli XLI-blue (Agilent Technologies, Santa Clara, CA, USA) strains were pre-grown at 37 °C and S. cerevisiae strains at 30 °C and at 200 rpm in an Innova incubator shaker (New Brunswick Scientific, Edison NJ). Stationary-phase cultures were supplemented with 30% (w/v) glycerol and stored at − 80 °C.

Table 4.

S. cerevisiae strains used in this study

Strain Relevant genotype Reference
CEN.PK 113-5D MATa HIS3 LEU2 TRP1 ura3-52 (Entian and Kötter 2007)
CEN.PK 113-7D MATa HIS3 LEU2 TRP1 URA3 (Entian and Kötter 2007)
IMX581 MATa HIS3 LEU2 TRP1 ura3-52 can1::cas9-natNT2 Mans et al. (2015)
IMX585 MATa HIS3 LEU2 TRP1 URA3 can1::cas9-natNT2 Mans et al. (2015)
IMK824 MATa HIS3 LEU2 TRP1 URA3 can1::cas9-natNT2 ura1 This study
IMI433 MATa HIS3 LEU2 TRP1 URA3 can1::cas9-natNT2 ura1::Aadho This study
IMI434 MATa HIS3 LEU2 TRP1 URA3 can1::cas9-natNT2 ura1::Scdho This study
IME410 MATa HIS3 LEU2 TRP1 ura3-52 pUDE737 This study
IME414 MATa HIS3 LEU2 TRP1 ura3-52 pUDE736 This study
IME426 MATa HIS3 LEU2 TRP1 ura3-52 pUD63 This study
IME664 MATa HIS3 LEU2 TRP1 URA3 can1::cas9-natNT2 ura1∆ pUDE737 This study
IME665 MATa HIS3 LEU2 TRP1 URA3 can1::cas9-natNT2 ura1∆ pUDE736 This study

Molecular biology techniques

PCR was performed with Phusion High-Fidelity Polymerase (Thermo Fisher Scientific, Waltham MA) or DreamTaq (Thermo Fisher) for cloning and diagnostic purposes, respectively. Oligonucleotide primers (SI Table S1) were purchased from Sigma-Aldrich. PCR products amplified from plasmid templates were digested with FastDigest DpnI (Thermo Fisher) to avoid contamination with template DNA. Fragment sizes were analysed by electrophoresis on 1% (w/v) agarose gels. PCR products were purified with the GeneElute PCR Clean-Up Kit (Sigma-Aldrich) or the Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine CA). Plasmids were purified using with a GeneElute Plasmid Miniprep Kit (Sigma-Aldrich).

Plasmid construction

Coding regions of DHO genes from A. alternata (A0A177DSV5) and Sch. commune (D8QKJ0), referred to as Aadho and Scdho, respectively, were derived from the UniProt Database (The UniProt Consortium 2019). Plasmids pUD709 (Aadho) and pUD708 (Scdho), carrying versions of these sequences that were codon optimised for expression in S. cerevisiae using the online GeneOptimizer tool (Raab et al. 2010) and obtained from GeneArt (Regensburg, Germany; Table 5). Coding regions were PCR amplified from these plasmids using primer pairs 12,365/12366 and 12363/12364, respectively. A pUDE63 backbone, containing a TDH3 promoter and an AHD1 terminator, was PCR amplified with primer pair 7823/7998, followed by Gibson Assembly (New England Biolabs, Ipswich MA; Gibson et al. 2009) with the Aadho and Scdho coding regions. The resulting plasmids pUDE737 (TDH3p-Aadho-ADH1t) and pUDE736 (TDH3p-Scdho-ADH1t) carried yeast expression cassettes for the two putative dho genes. pUDR348, which carries an expression cassette for a guide RNA targeting the URA1 locus of S. cerevisiae IMX585 (can1∆::cas9-natNT2) was constructed by Gibson assembly of a pMEL13 backbone and 2 µm fragment as described previously (Mans et al. 2015). The pMEL13 backbone was amplified with PCR primer 6005 and the 2 µm fragment with primer pair 11,334/11335 (SI Table S2). E. coli XLI-Blue was transformed with the constructed plasmids and incubated for 5 min on ice, followed by 1 h incubation at 37 °C prior to plating on LB with ampicillin.

Table 5.

Plasmids used in this study

Plasmid Relevant characteristics Purpose Reference
pUD63 2 µm ampR URA3 TDH3p-ADH1t Empty vector de Kok et al. (2011)
pUD708 ampR Scdho Template GeneArt
pUD709 ampR Aadho Template GeneArt
pMEL13 2 µm ampR kanMX gRNA-CAN1 Template Mans et al. (2015)
pUDE63 2 µm ampR URA3 TDH3p-pgmB-ADH1t Template de Kok et al. (2011)
pUDE736 2 µm ampR URA3 TDH3p-Scdho-ADH1t Expression Scdho This study
pUDE737 2 µm ampR URA3 TDH3p-Aadho-ADH1t Expression Aadho This study
pUDR348 2 µm ampR kanMX gRNA-URA1 Targeting URA1 This study

Strain construction

S. cerevisiae strains were transformed with 1–2 µg plasmid DNA by the LiAc/SS-DNA/PEG-method (Gietz and Woods 2002). Strains IME410, IME414 and IME426 were constructed by transformation of CEN.PK 113-5D (ura3-52) with plasmids pUDE737 (Aadho), pUDE736 (Scdho) and pUD63 (empty vector), respectively, followed by selection on SMD plates and diagnostic PCR. Similarly, IME664 (ura1Δ mcAadho) and IME665 (ura1Δ mcScdho) were constructed by transforming S. cerevisiae IMK824 (ura1Δ) with pUDE737 (Aadho) and pUDE736 (Scdho), respectively. Cas9-mediated deletion or integration of genes in the Cas9-expressing S. cerevisiae strain IMX585 (can1::cas9-natNT2; Mans et al. 2015) was done according to Dicarlo et al. (2013). The URA1 locus was targeted using the guide-RNA plasmid pUDR348. For construction of the ura1 deletion strain IMK824, strain IMX585 was co-transformed with a repair oligonucleotide obtained by annealing oligonucleotides 11,336 and 11,337 (SI Table S1) and pUDR348. For integration of expression cassettes of the putative dho genes from A. alternata and Sch. commune, repair fragments containing these genes with upstream and downstream flanking URA1 sequences, were amplified from pUDE736 and pUDE737, respectively, with primers 12,479 and 12,480. Integration of these fragments at the URA1 locus yielded strains IMI433 (ura1::Aadho) and IMI434 (ura1::Scdho), respectively.

Phylogeny of putative LkUra1 orthologs

For a systematic search for Ura1 orthologs, fungal proteomes (taxid 4751) available from the UniProt reference release 2019_02 (The UniProt Consortium 2019) were supplemented with sequences available from the UniProt trembl division for the following organisms: Dekkera bruxellensis (taxid 5007), Komagataella phaffii (taxid 981,350), Komagataella pseudopastoris (taxid 169,507), Komagataella pastoris (taxid 4922), Ogataea polymorpha (taxid 460,523), Pichia membranifaciens (taxid 763,406), Pichia kudriavzevii (taxid 4909), Neocallimastix californiae (taxid 1,754,190), Piromyces finnis (taxid 1,754,191), Anaeromyces_robustus (taxid 1,754,192) and Piromyces sp. E2 (taxid 73,868). The Ura1 sequence of Lachancea kluyveri CBS3082 (LkUra1, Q7Z892; Gojković et al. 2004) was used as query for a HMMER search of these sequences (Mistry et al. 2013). Cutoff values of 1e-5 were used, and hits were required to correspond to at least 75% of the query sequence length. From the resulting sequence, Ura1 orthologs were identified by calculating all possible co-ortholog sets with proteinortho v6.0.25 (Lechner et al. 2011) running diamond v2.0.8 (Buchfink et al. 2021). The resulting 203 fungal Ura1 orthologs (Dataset_S01) were subjected to a multiple sequence alignment using MAFFT v7.40286 (Katoh and Standley 2013) in “einsi” mode. Alignments were trimmed using trimAl v1.287 (Capella-Gutiérrez et al. 2009) in “gappyout” mode, and used to build a phylogenetic tree with RAxML-NG v0.8.188 (Kozlov et al. 2019) using 10 random and 10 parsimony starting trees, 100 Felsestein Bootstrap replicates, and LG model. The resulting phylogenetic tree (Dataset_S02) was visualised using iTOL (Interactive Tree Of Life) tool v6 (Letunic and Bork 2016). To search for fungal homologs of dihydropyrimidinase (DHP), a protein search (blastp; Camacho et al. 2009) was performed on fungal proteomes (taxid: 4751) with the DHP sequence of Lachancea kluyveri (Uniprot KB accession: Q9P903) as query. Resulting protein sequences with an E-value below 1e-5 are provided in Dataset_S03.

Aerobic growth experiments

Shake-flask cultures were grown in 500-mL flasks containing 100 mL of medium. A frozen stock culture was used to inoculate a pre-culture on SMD + ura. Upon reaching stationary phase, a 1-mL sample of this pre-culture was transferred to a second pre-culture on SMD + ura0.1. This second pre-culture was grown until late exponential phase, centrifuged (5 min at 3000 g), washed twice with sterile demineralised water and used as inoculum for either plate or shake-flask growth experiments. Shake flasks were incubated in an Innova incubator (New Brunswick Scientific), operated at 30 °C and at 200 rpm. Agar plates were incubated for 2 d at 30 °C. For cell sorting experiments, SMD was used for the first pre-culture, while the second culture was grown on either 1 mL SMD + ura0.1 supplemented with 5F-dhu or on 1 mL SMD + ura in a sterile 1.5-mL Eppendorf tube (Eppendorf Corporate, Hamburg, Germany).

Anaerobic cultivation

Anaerobic cultures were grown in a Bactron 300–2 anaerobic workstation (Sheldon Manufacturing Inc, Cornelius OR) equipped with a Pd-catalyst and filled with a mixed gas atmosphere (85% N2, 10% CO2, 5% H2). To minimise oxygen entry, the protocols described by Mooiman et al. (2021) for cultivation in anaerobic chambers were followed. Flasks were placed on an IKA KS 260 basic orbital shaker (IKA-Werke, Staufen im Breisgau, Germany) at 240 rpm and temperature in the workspace was maintained at 30 °C. Strains were pre-grown aerobically, centrifuged (3000 g, 5 min), washed with sterile demineralised water and used to inoculate medium in the anaerobic workspace. The initial optical density at 600 nm of anaerobic pre-cultures, which were grown on SMUD + dhu0.1 or SMUD + ura0.1 was 0.2. Stationary-phase pre-cultures were used to start subsequent anaerobic growth experiments on SMUD or SMUD + dhu. All anaerobic (pre-)cultures were supplemented with Tween 80 and ergosterol.

Analytical methods and calculation

Optical density of aerobic cultures was measured at 660 nm (OD660) with a Jenway 7200 Spectrophotometer (Bibby Scientific, Staffordshire, UK). Maximum specific growth rates were calculated from the slope of ln OD660 versus time during the exponential phase, considering at least six time points. Optical density measurements in anaerobic cultures were performed at 600 nm with an Ultrospec 10 cell density meter (Biochrom, Harvard Biosience, Holliston MA) placed in the anaerobic workstation. For spot-plate experiments, cell counts in late-exponential-phase shake-flask cultures were first determined using a Z2 Coulter Counter Analyzer (Beckman Coulter Life Sciences, Indianapolis IN) following the manufacturer’s protocol. Prior to analysis, cultures were diluted one 100-fold with Isoton II (Beckman Coulter, Brea CA), followed by five replicate cell counts on each sample.

Enzyme assays

Cell extracts were prepared by sonication and centrifugation (Vuralhan et al. 2005) of cells grown aerobically on SMUD + dhu until late-exponential phase. Protein concentrations in cell extracts were determined with the Lowry method (Lowry et al. 1951) and with bovine serum albumin as reference. Oxygen consumption was measured with a Clark-type oxygen electrode at 30 °C in 0.1 M potassium phosphate buffer (pH 7.5) with 2 mM MgCl2 as described previously (Visser et al. 1995), using two independently prepared cell extracts for each yeast strain. Air-saturated buffer (236 μM O2) was used to calibrate the oxygen electrode. Assays were performed in a reaction volume of 4 mL and started by addition of dihydrothymine or dihydrouracil (final concentration 1 mM). Production of H2O2 was tested by addition of 4 μL catalase suspension from bovine liver (500 U mL−1; Sigma Aldrich) during the reaction.

Viability and plasmid loss assays

Single cells were sorted with a BD FACSAria II SORP cell sorter (BD Biosciences) as described previously (Gorter de Vries et al. 2019), with the modification that cells were sorted based on forward scatter (FSC) and side scatter (SSC) instead of fluorescence. Late-exponential-phase cultures grown on either SMD + ura + 5F-dhu or on SMD were diluted ten-fold in sterile Isoton II (Beckman Coulter) and > 105 events were analysed. The FSC of analysed events was plotted against the SSC to set the sorting region such that bias for cell morphology was avoided. Unless indicated differently, 4 × 384 single cells were sorted from each culture using the single-cell sorting mask (0/32/16), and placed on two SMD and two SMD + ura plates.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

We thank Charlotte Koster for help with the FACS analyses and our colleagues at the Industrial Microbiology group of TU Delft for inspiring discussions.

Author contributions

JB, AMV, MAHL and JTP designed wet-lab experiments, and experimental procedures were performed by JB, DCC and MAHL. Sequence analyses were designed and performed by RAOM and data analysis was performed by RAOM, JB and AMV. JB and JTP wrote the draft manuscript with all authors providing critical feedback. The final version was approved by all authors.

Funding

This work was supported by an Advanced Grant of the European Research Council [grant 694633 to J.T.P].

Data availability

All data generated or analysed in this study are included in the article and supplementary information files.

Code availability

Not applicable.

Declarations

Conflicts of interest

Authors declare no conflicts of interest.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Ethics approval

Not applicable.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jonna Bouwknegt and Aurin M. Vos have contributed equally to this work, and should be considered co-first authors.

References

  1. Andersen G, Merico A, Björnberg O, Andersen B, Schnackerz KD, Dobritzsch D, Piškur J, Compagno C. Catabolism of pyrimidines in yeast: a tool to understand degradation of anticancer drugs. Nucleosides, Nucleotides Nucleic Acids. 2006;25:991–996. doi: 10.1080/15257770600889386. [DOI] [PubMed] [Google Scholar]
  2. Andersen G, Björnberg O, Polakova S, Pynyaha Y, Rasmussen A, Møller K, Hofer A, Moritz T, Sandrini MPB, Merico AM, Compagno C, Åkerlund HE, Gojković Z, Piškur J. A second pathway to degrade pyrimidine nucleic acid precursors in eukaryotes. J Mol Biol. 2008;380:656–666. doi: 10.1016/j.jmb.2008.05.029. [DOI] [PubMed] [Google Scholar]
  3. Arakaki TL, Buckner FS, Gillespie JR, Malmquist NA, Phillips MA, Kalyuzhniy O, Luft JR, Detitta GT, Verlinde CLMJ, Van VWC, Hol WGJ, Ethan A. Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies. Mol Microbiol. 2008;68:37–50. doi: 10.1111/j.1365-2958.2008.06131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartnicki-Garcia S, Nickerson WJ. Nutrition, growth and morphogenesis of Mucor rouxii. J Bacteriol. 1962;84:841–858. doi: 10.1128/jb.84.4.841-858.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Basbous J, Aze A, Chaloin L, Lebdy R, Hodroj D, Ribeyre C, Larroque M, Shepard C, Kim B, Pruvost A, Moreaux J, Maiorano D, Mechali M, Constantinou A. Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites. Nucleic Acids Res. 2020;48:1886–1904. doi: 10.1093/nar/gkz1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Berger R, Stoker-de Vries SA, Wadman SK, Duran M, Beemer FA, de Bree PK, Weits-Binnerts JJ, Penders TJ, van der Woude JK. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism. Clin Chim Acta. 1984;141:227–34. doi: 10.1016/0009-8981(84)90014-7. [DOI] [PubMed] [Google Scholar]
  7. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol. 1951;62:293–300. doi: 10.1128/jb.62.3.293-300.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Björnberg O, Rowland P, Larsen S, Jensen KF. Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. Biochemistry. 1997;36:16197–16205. doi: 10.1021/bi971628y. [DOI] [PubMed] [Google Scholar]
  9. Bouwknegt J, Koster CC, Vos AM, Ortiz-Merino RA, Wassink M, Luttik MAH, van den Broek M, Hagedoorn PL, Pronk JT. Class-II dihydroorotate dehydrogenases from three phylogenetically distant fungi support anaerobic pyrimidine biosynthesis. Fungal Biol Biotechnol. 2021;8:1–18. doi: 10.1186/s40694-021-00117-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brooks KP, Dong Kim B, Sander EG. Dihydropyrimidine amidohydrolase is a zinc metalloenzyme. Biochim Biophys Acta. 1979;570:213–214. doi: 10.1016/0005-2744(79)90216-X. [DOI] [PubMed] [Google Scholar]
  11. Buchfink B, Reuter K, Drost HG. Sensitive protein alignments at tree-of-life scale using DIAMOND. Nat Methods. 2021;18:366–368. doi: 10.1038/s41592-021-01101-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:1–9. doi: 10.1186/1471-2105-10-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cambell LL. Reductive degradation of pyrimidines. II. Mechanism of uracil degredation by Clostridium uracilicum. J Bacteriol. 1956;73:225–9. doi: 10.1128/jb.73.2.225-229.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Capella-Gutiérrez S, Silla-Martínez JM, Gabaldón T. trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics. 2009;25:1972–1973. doi: 10.1093/bioinformatics/btp348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Davis CH, Putnam MD, Thwaites WM. Metabolism of dihydrouracil in Rhodosporidium toruloides. J Bacteriol. 1984;158:347–350. doi: 10.1128/jb.158.1.347-350.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Kok S, Yilmaz D, Suir E, Pronk JT, Daran JM, van Maris AJA. Increasing free-energy (ATP) conservation in maltose-grown Saccharomyces cerevisiae by expression of a heterologous maltose phosphorylase. Metab Eng. 2011;13:518–526. doi: 10.1016/j.ymben.2011.06.001. [DOI] [PubMed] [Google Scholar]
  17. di Carlo FJ, Schultz AS, Kent AM. Cytosine antagonism in yeast by diazobarbituric anhydride. J Biol Chem. 1952;194:769–774. doi: 10.1016/S0021-9258(18)55831-2. [DOI] [PubMed] [Google Scholar]
  18. Dicarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res. 2013;41:4336–4343. doi: 10.1093/nar/gkt135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dobritzsch D, Schneider G, Schnackerz KD, Lindqvist Y. Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil. EMBO J. 2001;20:650–660. doi: 10.1093/emboj/20.4.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dobritzsch D, Andersen B, Piškur J. Crystallization and X-ray diffraction analysis of dihydropyrimidinase from Saccharomyces kluyveri. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005;61:359–362. doi: 10.1107/S174430910500610X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Entian KD, Kötter P (2007) Yeast genetic strain and plasmid collections. In: Stansfield, I. , and Stark MJR (ed.). Methods in Microbiology: Yeast Gene Analysis. Vol 36. 2nd ed. Amsterdam: Academic Press, 629–66.
  22. Fonseca GG, Heinzle E, Wittmann C, Gombert AK. The yeast Kluyveromyces marxianus and its biotechnological potential. Appl Microbiol Biotechnol. 2008;79:339–354. doi: 10.1007/s00253-008-1458-6. [DOI] [PubMed] [Google Scholar]
  23. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6:343–345. doi: 10.1038/nmeth.1318. [DOI] [PubMed] [Google Scholar]
  24. Gietz RD, Woods RA. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol. 2002;350:87–96. doi: 10.1016/S0076-6879(02)50957-5. [DOI] [PubMed] [Google Scholar]
  25. Gojković Z, Knecht W, Zameitat E, Warneboldt J, Coutelis JB, Pynyaha Y, Neuveglise C, Møller K, Löffler M, Piškur J. Horizontal gene transfer promoted evolution of the ability to propagate under anaerobic conditions in yeasts. Mol Genet Genomics. 2004;271:387–393. doi: 10.1007/s00438-004-0995-7. [DOI] [PubMed] [Google Scholar]
  26. Gorter de Vries AR, Koster CC, Weening SM, Luttik MAH, Kuijpers NGA, Geertman JMA, Pronk JT, Daran JMG. Phenotype-independent isolation of interspecies Saccharomyces hybrids by dual-dye fluorescent staining and fluorescence-activated cell sorting. Front Microbiol. 2019;10:1–12. doi: 10.3389/fmicb.2019.00871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Grigoriev IV, Nikitin R, Haridas S, Kuo A, Ohm R, Otillar R, Riley R, Salamov A, Zhao X, Korzeniewski F, Smirnova T, Nordberg H, Dubchak I, Shabalov I (2014) MycoCosm portal: gearing up for 1000 fungal genomes. Nucleic Acids Res 42:699–704 [DOI] [PMC free article] [PubMed]
  28. Hall C, Brachat S, Dietrich FS. Contribution of horizontal gene transfer to the evolution of Saccharomyces cerevisiae. Eukaryot Cell. 2005;4:1102–1115. doi: 10.1128/EC.4.6.1102-1115.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hayaishi O, Kornberg A. Metabolism of cytosine, thymine, uracil, and barbituric acid by bacterial enzymes. J Biol Chem. 1952;197:717–732. doi: 10.1016/S0021-9258(18)55628-3. [DOI] [PubMed] [Google Scholar]
  30. Heggie GD, Sommadossi JP, Cross DS, Huster WJ. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 1987;47:2203–2206. [PubMed] [Google Scholar]
  31. Hey-Mogensen M, Goncalves RLS, Orr AL, Brand MD. Production of superoxide/H2O2 by dihydroorotate dehydrogenase in rat skeletal muscle mitochondria. Free Radic Biol Med. 2014;72:149–155. doi: 10.1016/j.freeradbiomed.2014.04.007. [DOI] [PubMed] [Google Scholar]
  32. Hull WE, Port RE, Herrmann R, Britsch B, Kunz W. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment. Cancer Res. 1988;48:1680–1688. [PubMed] [Google Scholar]
  33. Jeennor S, Laoteng K, Tanticharoen M, Cheevadhanarak S. Comparative fatty acid profiling of Mucor rouxii under different stress conditions. FEMS Microbiol Lett. 2006;259:60–66. doi: 10.1111/j.1574-6968.2006.00242.x. [DOI] [PubMed] [Google Scholar]
  34. Jund R, Weber E, Chevallier M-R. Primary structure of the uracil transport protein of Saccharomyces cerevisiae. Eur J Biochem. 1988;171:417–424. doi: 10.1111/j.1432-1033.1988.tb13806.x. [DOI] [PubMed] [Google Scholar]
  35. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30:772–780. doi: 10.1093/molbev/mst010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kikugawa M, Kaneko M, Fujimoto-Sakata S, Maeda M, Kawasaki K, Takagi T, Tamaki N. Purification characterization and inhibition of dihydropyrimidinase from rat liver. Eur J Biochem. 1994;219:393–399. doi: 10.1111/j.1432-1033.1994.tb19951.x. [DOI] [PubMed] [Google Scholar]
  37. Kozlov AM, Darriba D, Flouri T, Morel B, Stamatakis A. RAxML-NG: A fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics. 2019;35:4453–4455. doi: 10.1093/bioinformatics/btz305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Längle-rouault F, Jacobs E. A method for performing precise alterations in the yeast genome using a recyclable selectable marker. Nucleic Acids Res. 1995;23:3079–3081. doi: 10.1093/nar/23.15.3079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lechner M, Findeiß S, Steiner L, Marz M, Stadler PF, Prohaska SJ. Proteinortho : detection of ( Co- ) orthologs in large-scale analysis. BMC Bioinformatics. 2011;12:1–9. doi: 10.1186/1471-2105-12-124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016;44:W242–W245. doi: 10.1093/nar/gkw290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Li Y, Steenwyk JL, Chang Y, Wang Y, James TY, Stajich JE, Spatafora JW, Groenewald M, Dunn CW, Hittinger CT, Shen XX, Rokas A. A genome-scale phylogeny of the kingdom Fungi. Curr Biol. 2021;31:1653–1665.e5. doi: 10.1016/j.cub.2021.01.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Loh KDI, Gyaneshwar P, Markenscoff Papadimitriou E, Fong R, Kim KS, Parales R, Zhou Z, Inwood W, Kustu S. A previously underscribed pathway for pyrimidine catabolism. Proc Natl Acad Sci U S A. 2006;103:5114–5119. doi: 10.1073/pnas.0600521103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein determination with the folin phenol reagent. J Biol Chem. 1951;193:265–276. doi: 10.1016/S0021-9258(19)52451-6. [DOI] [PubMed] [Google Scholar]
  44. Lu ZH, Zhang R, Diasio RB. Purification and characterization of dihydropyrimidine dehydrogenase from human liver. J Biol Chem. 1992;267:17102–17109. doi: 10.1016/S0021-9258(18)41899-6. [DOI] [PubMed] [Google Scholar]
  45. Luttik MAH, Kötter P, Salomons FA, van der Klei IJ, van Dijken JP, Pronk JT. The Saccharomyces cerevisiae ICL2 gene encodes a mitochondrial 2-methylisocitrate lyase involved in propionyl-coenzyme a metabolism. J Bacteriol. 2000;182:7007–7013. doi: 10.1128/JB.182.24.7007-7013.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Mans R, van Rossum HM, Wijsman M, Backx A, Kuijpers NGA, van den Broek M, Daran-Lapujade P, Pronk JT, van Maris AJA, Daran J-MG. CRISPR/Cas9: a molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae. FEMS Yeast Res. 2015;15:fov004. doi: 10.1093/femsyr/fov004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mans R, Hassing EJ, Wijsman M, Giezekamp A, Pronk JT, Daran JM, van Maris AJA. A CRISPR/Cas9-based exploration into the elusive mechanism for lactate export in Saccharomyces cerevisiae. FEMS Yeast Res. 2017;17:1–12. doi: 10.1093/femsyr/fox085. [DOI] [PubMed] [Google Scholar]
  48. Mistry J, Finn RD, Eddy SR, Bateman A, Punta M. Challenges in homology search: HMMER3 and convergent evolution of coiled-coil regions. Nucleic Acids Res. 2013;41:121. doi: 10.1093/nar/gkt263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Moffatt B, Ashihara H. Purine and pyrimidine nucleotide synthesis and metabolism. Arab B. 2002;1:e0018. doi: 10.1199/tab.0018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Mooiman C, Bouwknegt J, Dekker WJC, Wiersma SJ, Ortiz-Merino RA, de Hulster EAF, Pronk JT. Critical parameters and procedures for anaerobic cultivation of yeasts in bioreactors and anaerobic chambers. FEMS Yeast Res. 2021;21:foab035. doi: 10.1093/femsyr/foab035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Nagy M, Lacroute F, Thomas D. Divergent evolution of pyrimidine biosynthesis between anaerobic and aerobic yeasts. Proc Natl Acad Sci U S A. 1992;89:8966–8970. doi: 10.1073/pnas.89.19.8966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. O’Donovan GA, Neuhard J. Pyrimidine metabolism in microorganisms. Bacteriol Rev. 1970;34:278–343. doi: 10.1128/br.34.3.278-343.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Oliver JD, Sibley GEM, Beckmann N, Dobb KS, Slater MJ, McEntee L, Du Pré S, Livermore J, Bromley MJ, Wiederhold NP, Hope WW, Kennedy AJ, Law D, Birch M. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci U S A. 2016;113:12809–12814. doi: 10.1073/pnas.1608304113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Owaki J, Uzura K, Minami Z, Kusai K. Partial purification and characterization of dihydrouracil oxidase, a flavoprotein from Rhodotorula glutinis. J Ferment Technol. 1986;64:205–210. doi: 10.1016/0385-6380(86)90100-7. [DOI] [Google Scholar]
  55. Piškur J, Ling Z, Marcet-Houben M, Ishchuk OP, Aerts A, LaButti K, Copeland A, Lindquist E, Barry K, Compagno C, Bisson L, Grigoriev I V., Gabaldón T, Phister T (2012) The genome of wine yeast Dekkera bruxellensis provides a tool to explore its food-related properties. Int J Food Microbiol 157:202–209 [DOI] [PubMed]
  56. Podschun B, Wahler G, Schnackerz KD. Purification and characterization of dihydropyrimdine dehydrogenase from pig liver. Eur J Biochem. 1989;185:219–224. doi: 10.1111/j.1432-1033.1989.tb15105.x. [DOI] [PubMed] [Google Scholar]
  57. Podschun B, Cook PF, Schnackerz KD. Kinetic mechanism of dihydropyrimidine dehydrogenase from pig liver. J Biol Chem. 1990;265:12966–12972. doi: 10.1016/S0021-9258(19)38254-7. [DOI] [PubMed] [Google Scholar]
  58. Pronk JT. Auxotrophic yeast strains in fundamental and applied research. Appl Environ Microbiol. 2002;68:2095–2100. doi: 10.1128/AEM.68.5.2095-2100.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Raab D, Graf M, Notka F, Schödl T, Wagner R. The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization. Syst Synth Biol. 2010;4:215–225. doi: 10.1007/s11693-010-9062-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Rawls J, Knecht W, Diekert K, Lill R, Löffler M. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase. Eur J Biochem. 2000;267:2079–2087. doi: 10.1046/j.1432-1327.2000.01213.x. [DOI] [PubMed] [Google Scholar]
  61. Riley R, Haridas S, Wolfe KH, et al. Comparative genomics of biotechnologically important yeasts. Proc Natl Acad Sci U S A. 2016;113:9882–9887. doi: 10.1073/pnas.1603941113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Rowland P, Nielsen FS, Jensen KF, Larsen S. The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase a from Lactococcus lactis. Structure. 1997;5:239–252. doi: 10.1016/S0969-2126(97)00182-2. [DOI] [PubMed] [Google Scholar]
  63. Shiotani T, Weber G. Purification and properties of dihydrothymine dehydrogenase from rat liver. J Biol Chem. 1981;256:219–224. doi: 10.1016/S0021-9258(19)70122-7. [DOI] [PubMed] [Google Scholar]
  64. Smith A, Yamada E. Dihydrouracil dehydrogenase of rat liver. J Biol Chem. 1971;246:3610–3617. doi: 10.1016/S0021-9258(18)62172-6. [DOI] [PubMed] [Google Scholar]
  65. The UniProt Consortium UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506–D515. doi: 10.1093/nar/gky1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Van Gennip AH, Abeling NGGM, Vreken P, Van Kuilenburg ABP. Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects. J Inherit Metab Dis. 1997;20:203–213. doi: 10.1023/A:1005356806329. [DOI] [PubMed] [Google Scholar]
  67. van Kuilenburg ABP, van Vreken P, Abeling NGGM, et al. Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet. 1999;104:1–9. doi: 10.1007/PL00008711. [DOI] [PubMed] [Google Scholar]
  68. Venkhataraman R, Donald CD, Roy R, You HJ, Doetsch PW, Kow YW (2001) Enzymatic processing of DNA containing tandem dihydrouracil by endonucleases III and VIII. Nucleic Acids Res 29:407–414 [DOI] [PMC free article] [PubMed]
  69. Verduyn C, Postma E, Scheffers WA, van Dijken JP. Effect of benzoic acid on metabolic fluxes in yeasts: A continuous-culture study on the regulation of respiration and alcoholic fermentation. Yeast. 1992;8:501–517. doi: 10.1002/yea.320080703. [DOI] [PubMed] [Google Scholar]
  70. Visser W, van Spronsen EA, Nanninga N, Pronk JT, Kuenen JG, van Dijken JP. Effects of growth conditions on mitochondrial morphology in Saccharomyces cerevisiae. Antonie Van Leeuwenhoek. 1995;67:243–253. doi: 10.1007/BF00873688. [DOI] [PubMed] [Google Scholar]
  71. Vogels GD, van der Drift C. Degradation of purines and pyrimidines by microorganisms. Bacteriol Rev. 1976;40:403–468. doi: 10.1128/br.40.2.403-468.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Vuralhan Z, Luttik MAH, Tai SL, Boer VM, Morais MA, Schipper D, Almering MJH, Kötter P, Dickinson JR, Daran JM, Pronk JT. Physiological characterization of the ARO10-dependent, broad-substrate- specificity 2-oxo acid decarboxylase activity of Saccharomyces cerevisiae. Appl Environ Microbiol. 2005;71:3276–3284. doi: 10.1128/AEM.71.6.3276-3284.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Wierzchowski KL, Schugar D. Photochemistry of cytosine nucleosides and nucleotides. Biochim Biophys Acta. 1957;25:355–364. doi: 10.1016/0006-3002(57)90479-1. [DOI] [PubMed] [Google Scholar]
  74. Woolfit M, Rozpȩdowska E, Piškur J, Wolfe KH (2007) Genome survey sequencing of the wine spoilage yeast Dekkera (Brettanomyces) bruxellensis. Eukaryot Cell 6:721–733 [DOI] [PMC free article] [PubMed]
  75. Yakovlev DY, Skuridin SG, Khomutov AR, Yevdokimov YM, Khomutov RM. The reduction of thymine residues in DNA by the combined action of UV light and hypophosphite. J Photochem Photobiol B Biol. 1995;29:119–123. doi: 10.1016/1011-1344(95)07134-N. [DOI] [PubMed] [Google Scholar]
  76. Zameitat E, Pierik AJ, Zocher K, Löffler M. Dihydroorotate dehydrogenase from Saccharomyces cerevisiae: Spectroscopic investigations with the recombinant enzyme throw light on catalytic properties and metabolism of fumarate analogues. FEMS Yeast Res. 2007;7:897–904. doi: 10.1111/j.1567-1364.2007.00275.x. [DOI] [PubMed] [Google Scholar]
  77. Zrenner R, Stitt M, Sonnewald U, Boldt R. Pyrimidine and purine biosynthesis and degradation in plants. Annu Rev Plant Biol. 2006;57:805–836. doi: 10.1146/annurev.arplant.57.032905.105421. [DOI] [PubMed] [Google Scholar]
  78. Zrenner R, Riegler H, Marquard CR, Lange PR, Geserick C, Bartosz CE, Chen CT, Slocum RD. A functional analysis of the pyrimidine catabolic pathway in Arabidopsis. New Phytol. 2009;183:117–132. doi: 10.1111/j.1469-8137.2009.02843.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

All data generated or analysed in this study are included in the article and supplementary information files.

Not applicable.


Articles from Antonie Van Leeuwenhoek are provided here courtesy of Springer

RESOURCES